206 related articles for article (PubMed ID: 31485913)
41. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30.
Lundy JJ; Coons SJ; Aaronson NK
Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466
[TBL] [Abstract][Full Text] [Related]
42. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
[TBL] [Abstract][Full Text] [Related]
43. Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30.
Lundy JJ; Coons SJ; Aaronson NK
Qual Life Res; 2014 Feb; 23(1):229-37. PubMed ID: 23765449
[TBL] [Abstract][Full Text] [Related]
44. Fatigue in the general population: German normative values of the EORTC QLQ-FA12.
Hinz A; Weis J; Brähler E; Mehnert A
Qual Life Res; 2018 Oct; 27(10):2681-2689. PubMed ID: 29909484
[TBL] [Abstract][Full Text] [Related]
45. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
46. Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.
Bulamu NB; Chen G; Ratcliffe J; Schloite A; Bright T; Watson DI
World J Surg; 2019 Jun; 43(6):1554-1562. PubMed ID: 30719557
[TBL] [Abstract][Full Text] [Related]
47. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
[TBL] [Abstract][Full Text] [Related]
48. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
[TBL] [Abstract][Full Text] [Related]
49. EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population.
Young T; Velikova G; Liegl G; Rose M; Nolte S;
Eur J Cancer; 2024 Jun; 204():113927. PubMed ID: 38429166
[TBL] [Abstract][Full Text] [Related]
50. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
51. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
52. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Weis J; Arraras JI; Conroy T; Efficace F; Fleissner C; Görög A; Hammerlid E; Holzner B; Jones L; Lanceley A; Singer S; Wirtz M; Flechtner H; Bottomley A
Psychooncology; 2013 May; 22(5):1002-7. PubMed ID: 22565359
[TBL] [Abstract][Full Text] [Related]
53. [Utility of the questionnaire for quality of life EORTC-QLQ-C30 in psycho-oncological outcome research].
Determann MM; Kollenbaum VE; Henne-Bruns D
Zentralbl Chir; 2004 Jan; 129(1):14-7. PubMed ID: 15011106
[TBL] [Abstract][Full Text] [Related]
54. Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.
Nielsen LK; Schjesvold F; Möller S; Guldbrandsen N; Hansson M; Remes K; Peceliunas V; Abildgaard N; Gregersen H; King MT
J Patient Rep Outcomes; 2024 Feb; 8(1):15. PubMed ID: 38315268
[TBL] [Abstract][Full Text] [Related]
55. Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
Beck ACC; Kieffer JM; Retèl VP; van Overveld LFJ; Takes RP; van den Brekel MWM; van Harten WH; Stuiver MM
PLoS One; 2019; 14(12):e0226077. PubMed ID: 31834892
[TBL] [Abstract][Full Text] [Related]
56. Symptoms and health-related quality of life in patients with advanced cancer - A population-based study in Greenland.
Augustussen M; Sjøgren P; Timm H; Hounsgaard L; Pedersen ML
Eur J Oncol Nurs; 2017 Jun; 28():92-97. PubMed ID: 28478862
[TBL] [Abstract][Full Text] [Related]
57. Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study.
Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
Support Care Cancer; 2020 Apr; 28(4):1725-1735. PubMed ID: 31297593
[TBL] [Abstract][Full Text] [Related]
58. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?
Hinz A; Einenkel J; Briest S; Stolzenburg JU; Papsdorf K; Singer S
Eur J Cancer Care (Engl); 2012 Sep; 21(5):677-83. PubMed ID: 22624663
[TBL] [Abstract][Full Text] [Related]
59. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
60. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
